INMNasdaqPharmaceutical PreparationsFiscal year ends June 30
InMed Pharmaceuticals Inc.
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 9, 2026
$1.37+0.05 (+3.44%)
Close on Oct 19, 2026
- Market cap
- $6.42M
- P/E (TTM)
- –
- Dividend yield
- –
InMed Pharmaceuticals statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | InMed Pharmaceuticals | Industry median |
|---|---|---|
| Market Cap | $7.50M | $164.85M |
| Enterprise Value | $5.30M | $87.06M |
| PB Ratio | 6.98 | 2.03 |
| P/TBV Ratio | 6.98 | 2.31 |
Income (trailing twelve months)
| Measure | InMed Pharmaceuticals | Industry median |
|---|---|---|
| Pretax Income | -$11.37M | -$14.45M |
| Net Income | -$12.56M | -$22.46M |
| EBITDA | -$11.17M | -$16.91M |
| EPS (Diluted) | -$3.12 | -$0.83 |
Returns
| Measure | InMed Pharmaceuticals | Industry median |
|---|---|---|
| Return on Equity (ROE) | -173.1% | -53.1% |
| Return on Assets (ROA) | -135.0% | -41.0% |
Balance sheet
| Measure | InMed Pharmaceuticals | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $2.20M | $62.42M |
| Net Cash (Debt) | $2.20M | $15.68M |
| Net Cash Per Share | $0.40 | $0.66 |
| Equity (Book Value) | $1.08M | $48.79M |
| Book Value Per Share | $0.20 | $1.36 |
| Tangible Book Value | $1.08M | $23.06M |
| Working Capital | $721.65K | $75.77M |
Financial position
| Measure | InMed Pharmaceuticals | Industry median |
|---|---|---|
| Current Ratio | 1.37 | 3.30 |
| Quick Ratio | 1.13 | 2.39 |
Cash flow (trailing twelve months)
| Measure | InMed Pharmaceuticals | Industry median |
|---|---|---|
| Operating Cash Flow | -$8.64M | -$12.35M |
Efficiency
| Measure | InMed Pharmaceuticals | Industry median |
|---|---|---|
| Profits Per Employee | -$2.09M | -$703.34K |
| Employee Count | 6 | 74 |
Dividends and yields
| Measure | InMed Pharmaceuticals | Industry median |
|---|---|---|
| Earnings Yield | -167.5% | -22.7% |
Shares
| Measure | InMed Pharmaceuticals | Industry median |
|---|---|---|
| Shares Outstanding | 5,493,740 | 58,179,650 |
| Shares Change (YoY) | 326.6% | 11.1% |
| Shares Change (QoQ) | 61.1% | 0.54% |
| Float | 4,093,310 | 49,173,100 |
| Shares Held by Insiders | 25.5% | 11.6% |
| Shares Held by Institutions | 49.1% | 59.4% |
Scores
| Measure | InMed Pharmaceuticals | Industry median |
|---|---|---|
| Altman Z-Score | -57.58 | -0.24 |
| Piotroski F-Score | 1 | 4 |
Calculated by StockData from InMed Pharmaceuticals's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.